Text search:
Coalition
for
Epidemic
Preparedness
Innovations
(CEPI)
Featured
Recommendations
10
New Publications
10
Language
English
55
French
7
Spanish
5
Portuguese
3
Russian
3
Arabic
3
Chinese
2
German
2
Document type
Studies & Reports
18
No document type
17
Strategic & Response Plan
12
Fact sheets
6
Guidelines
5
Manuals
3
Training Material
1
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
12
Syria
2
Latin America and the Carribbean
2
Brazil
2
Colombia
1
Sierra Leone
1
Cameroon
1
Nigeria
1
Burkina Faso
1
Guinea
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
Western and Central Europe
1
East and Southern Africa
1
Bolivia
1
Bangladesh
1
Eastern Europe
1
Liberia
1
Authors & Publishers
World Health Organization WHO
16
Coalition for Epidemic Preparedness Innovations (CEPI)
3
Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO
2
IACG Interagency Coordination Group on Antimicral Resistance
2
Institute for Health Metrics and Evaluation (IHME)
2
Organisation Mondiale de la Santé OMS
2
Pan American Health Organisation PAHO
2
WHO
2
390: 898&ndash
1
912
1
Access to Medicine Foundation
1
ACT-Accelerator: An economic investment case & financing requirements
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Amnesty International
1
Amterdam Institute for Global health & Development aighd
1
and S. Mauder
1
B Watso, E.Togami et al.
1
BUKO Pharma-Kampagne/Gesundheit und Dritte Welt e.V.
1
C. Clift
1
Centro de Coordinación de Alertasy Emergencias Sanitarias
1
Civil Society 20 (C20) - Saudi Arabia 2020
1
Dennis, C.
1
E. Ross
1
Eastern Mediterranean Region
1
et al.
1
European & Developing Countries Clinical Trials Partnership EDCTTP
1
European Asylum Support Office
1
GAVI Alliance
1
Gavi, the Vaccine Alliance
1
Gelband, Hellen
1
Gerald Keusch, Keith McAdam, Patricia Cuff, Michelle Mancher, and Emily R. Busta
1
Germany’s National Public Health Institute (RKI), et al.
1
Global Preparedness Monitoring Board
1
Harvard Global Health Institute
1
hler, Oliver Razum, Jean-Olivier Schmidt
1
Horton, Susan, et al.
1
Ilona Kickbusch
1
Ilona Kickbusch, Christian Franz, Anna Holzscheiter, Iris Hunger, Albrecht Jahn, Carsten Kö
1
iMMAP
1
Imperial College COVID-19 Response Team
1
International Vaccines Task Force (IVTF)
1
Jamison, Dean T.
1
Lancet 2017;
1
Mauder, S.
1
Ministerio de Salud y Deportes Bolivia
1
Ministerio de Salud y Deportes Bolivia
1
Ministerio de sanidad - España
1
National Academies of Sciences, Engineering, and Medicine
1
Ndemic Creations
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Office for the Coordination of Humanitarian Affairs OCHA
1
OPAS
1
OPAS, OMS
1
Organisation Mondiale de la Santé
1
Organização Mundial da Saúde (OMS)
1
Rahman-Shepherd, A.
1
Reijer, P.
1
Robert Koch Institut RKI
1
The Chatham House
1
The World Bank
1
World Bank
1
World Health Organization (WHO)
1
World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and Global Outbreak Alert and Response Network (GOARN).
1
World Health Organization (WHO), The Global Fund, Gavi et al.
1
World Health Organization WHO and World Intellectual Property Organization
1
World Health Organization WHO, Regional Office of Europe
1
WTO, WHO, WIPO
1
Publication Years
2020-2024
53
2010-2019
11
Category
COVID-19
9
Disaster Preparedness
5
x MEDBOX Issue Brief & Annual Reports x
2
Studies & Reports
2
Protection & Security
2
Disease Prevention & Control
2
Communicable Diseases
1
Pharmacy & Technology
1
Sanitation
1
Infection Control & Prevention (IPC)
1
Medical Devices & Equipment
1
Guidelines
1
Humanitarian Crisis
1
WASH
1
General Guidelines
1
Health Systems
1
Global Health
1
Pharmacy & Technologies
1
Toolboxes
Access & Strategy
6
Fair Allocation & Ethical Aspects
6
COVAX Initiative
6
Health Financing Toolbox
6
Appeals and Response Plans
5
Country specific documents
5
Public Health
4
Prevention & Preparedness
4
Communication Material
4
General Information & Methodology
3
Local Action
2
International
2
COVID-19 Information
2
Immunization Guidelines
2
Dashboards & Resource Platforms
2
General Information
2
Assessment & Studies
1
Communication & Training
1
IPC
1
Europe
1
Vaccines & Immunization
1
Introduction to Global Health
1
Concepts of Global Health
1
Training
1
Research
1
Health Equity & Equality
1
GO pre-deployment training
1
Risk Communication & Community Engagement
1
Public Health
1
Infection Control General
1
Video & Audio
1
Coronavirus-App
1
For General Public & Community
1
Global Impact: Socio-economic, health services, TB & HIV
This 10th edition of the Institute for Health Metrics and Evaluation’s annual Financing Global Health report provides the most up-to-date estimates of development assistance for health, domestic spending on health, health spending on two key infectious diseases – malaria and HIV/AIDS – and fut...ure scenarios of health spending. Several transitions in global health financing inform this report: the influence of economic development on the composition of health spending; the emergence of other sources of development assistance funds and initiatives; and the increased availability of disease-specific funding data for the global health community. For funders and policymakers with sights on achieving 2030 global health goals, these estimates are of critical importance. They can be used for identifying funding gaps, evaluating the allocation of scarce resources, and comparing funding across time and countries.more
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...apacity as a crucial component of global epidemic preparedness. The IVTF was convened by the World Bank Group (WBG) and the Coalition for Epidemic Preparedness Innovations (CEPI) in October 2017.more
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...ted health, economic, and societal costs that are borne by countries, regions, and even all nations in the case of pandemics (which are worldwide epidemics). These risks also include the consequences of increasing antimicrobial resistance (AMR) and its spread within regions and globally. A necessary first step is to monitor whether a broad range of stakeholders are acting to prevent outbreaks from becoming epidemics, whether their capacities to respond to epidemics are robust, and whether preparedness to respond to pandemics and limit the resulting economic and health damage is improving. Analyzing the adequacy of these efforts is vitally important for the decisions of policymakers to invest in the public health and disaster-risk management capacities. Early and effective control of disease outbreaks prevents substantial health and economic costs whether or not the disease can spread globally and become a pandemic. more
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up international coordination and support; scaling up co...untry preparedness and response by pillar; and accelerating research and innovation. The report also discusses some of the key challenges faced so far, and provides an update on the resource requirements for the next phase of WHO’s response as part of an unprecedented whole-of-UN approach to the pandemic.more
In Control imparts knowledge, provokes reflection and triggers curiosity. The first half of the book provides an overview of the organisations, principles, frameworks and themes that every professional deploying to health emergencies should be aware of. The second half of the book provides practical... advice to help professionals survive and thrive during their mission – from staying healthy, protecting oneself from cyber-attacks and coping with stress to building trust among the host community or dealing with language barriers and the press.
This handbook is free of charge and can be made available in small quantities as long as supply lasts. To order, please send this form to: incontrol-handbook@rki.demore
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator
The ACT Accelerator is a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
COVAX is co-led by Gavi, the Coalition for Epide...mic Preparedness Innovations (CEPI) and WHO. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.more
the Principles for Dose-Sharing provide a framework for higher-income economies to make additional volumes secured via bilateral deals available through the Facility primarily to AMC participants, on an equitable basis. These principles outline that such doses must be safe and effective, available a...s early as possible and should be available in substantive volumes as early as possible in 2021 to enable rapid and flexible deployment by the Facility – supporting the overall goal of equitable access.
18 Dec 2020more
Ndemic CreationsWorld Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and Global Outbreak Alert and Response Network (GOARN).
(2021)
CC
Leading disease outbreak experts have come together to show gamers everywhere how to spot and stop a pandemic. The popular simulation Plague Inc: The Cure not only transports players into a global public health outbreak similar to the COVID-19 pandemic, but a new feature also provides expert comment...ary comparing decisions made by gamers to real-life scenarios.more
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future... supply security. In 2021, the AU set a target to produce and supply more than 60% of the vaccine doses on the continent by 2040.
In the last 18 months alone, more than 30 new African manufacturing projects have been announced and estimates indicate that the African vaccine market across all existing and projected novel products could range between US$ 2.8 billion and US$ 5.6 billion by 2040*, demonstrating the potential for a thriving regional industry to emerge.more
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of... the pandemic response capabilities united under COVAX may eventually be integrated into regional, national and sub national health systems, routine immunization programmes and future global pandemic preparedness and response (PPR) structures. Therefore, the working structures outlined in this document continue to evolve and the document provides a snapshot of the COVAX ways of working in the first half of 2022.more
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...istance for health has seemingly leveled off, global health spending continues to climb, outpacing economic growth in many countries. Total health spending for 2015, the most recent year for which data are available, was estimated to be $9.7 trillion (95% uncertainty interval: 9.7–9.8)*, up 4.7% (3.9–5.6) from the prior year, and accounted for 10% of the world’s total economy. With some sources of health spending growing and other types remaining steady, and with major variations in spending from country to country, it is more important than ever to understand where resources for health come from, where they go, and how they align with health needs. This information is critical for planning and is a necessary catalyst for change as we aim to close the gap on the unfinished agenda of the Millennium Development Goals (MDGs) and move forward toward universal health coverage (UHC) in the Sustainable Development Goals (SDGs) era.more
The greatest risk to persons engaging in international medical emergency response is poor preparation.
The In Control handbook hopes to provide a remedy.
At the time of writing, we are living through the Coronavirus (COVID-19) pandemic, a health emergency that disregards physical borders, brin...gs into focus social inequalities and affects people on every continent. This shared challenge requires unprecedented measures and the collaboration of the brightest minds to support global health protection through this crisis and beyond. Healthcare infrastructures have to be strengthened, public health capacities and processes upgraded, medical countermeasures and vaccinations found and psychosocial side-effects treated.
Solidarity is the normative order of the day and the human species has to collaborate to face this invisible threat. Hiding and living in fear is not an option in this interconnected world. We have both a responsibility and an opportunity to make substantial contributions to a safer, healthier and more sustainable future for us all.
The existence of this handbook is an impressive example of solidarity. Over 50 authors from more than 15 institutes and organisations have come together voluntarily within a very short time to make their expertise available and enable cross-sectoral thinking. Knowledge is bundled, resources are combined, information gaps are filled. The In Control handbook is not a theoretical treatise of possible dangers, but a collection of subject-matter expertise, written by experts and practitioners who have shaped health topics over the past 20 years in the most diverse corners of the world.
The Centre for International Health Protection at the Robert Koch Institute (RKI) is collaborating with its partners and investing heavily in the build-up of operational know-how and capacity to support health crisis response abroad. This is done by preparing and enabling professionals to deploy safely across the world to assist those in need. In Control addresses the multi-faceted challenges of an international deployment. Readers will find not only technical medical information, but also insights into, for example, the fragility of our environment, the cultural differences that influence risk communication or the dilemmas arising from social distancing. Legal principles are highlighted, along with ethical guidance to ensure that our actions and decisions correspond to the highest moral standards.more
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...velopment of next-generation vaccines against COVID-19 variants and we are planning studies to answer critical scientific questions related to the durability of immunity, effectiveness of mixed-vaccine regimens, and vaccine effectiveness in vulnerable populations such as pregnant women. We are also bringing forward our plans to develop vaccines that could protect against multiple COVID-19 variants and other coronavirus speciemore
As of December 2018, CEPI has secured more than USD $747million towards its USD $1billion funding target, with financial support provided by the Bill & Melinda Gates Foundation, the Wellcome Trust, the European Commission, and the governments of Australia, Belgium, Canada, Germany, Japan, Norway, an...d the UK. These funds are used to finance CEPI’s core activities in coordinating efforts and investing in the development of new vaccines and technologies to prevent and contain infectious disease epidemics.more
Board of Directors Report 2016-2017 of the Coalition for Epidemic Preparedness Innovations (CEPI) outlining financial information about CEPI regarding investors and accounts.
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the ...world will see another pandemic in the not-too-distant future; that random mutations occur often enough in microbes that help them survive and adapt; that new pathogens will inevitably find a way to break through our defenses; and that there is the increased potential for intentional or accidental release of a synthesized agent. Every expert commentary and every analysis in recent years tells us that the costs of inaction are immense. And yet, as
the havoc caused by the last outbreak turns into a fading memory, we become complacent and relegate the case for investing in preparedness on a back burner, only to bring it to the forefront when the next outbreak occurs. The result is that the world remains scarily vulnerable.more
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...ent in ACT-Accelerator is the world’s best bet and most viable solution for restarting the global economy. It is intended for governments, multilaterals, civil society, businesses and foundations and all those interested in the work required to change the course of the pandemic. The global deployment of ACT-Accelerator’s comprehensive package of tools will reduce the severity of COVID-19 disease, enabling countries to transition out of the crisis thereby restarting domestic and international economic engines driving our global economy.more
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...nce then, US$ 10 billion has been raised for the AMC to procure vaccines and support delivery. Despite a challenging supply situation, COVAX has now shipped one billion doses to 144 countries, including over 870 million to AMC economies.more